TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $790,000 | +199.2% | 45,000 | -25.0% | 0.06% | +255.6% |
| Q2 2017 | $264,000 | +187.0% | 60,013 | +269.6% | 0.02% | +100.0% |
| Q4 2016 | $92,000 | -29.8% | 16,239 | +11.1% | 0.01% | -47.1% |
| Q2 2016 | $131,000 | -26.4% | 14,614 | -26.1% | 0.02% | -59.5% |
| Q4 2014 | $178,000 | – | 19,783 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 2,100,000 | $646,000 | 0.05% |
| Matrix Capital Management Company, LP | 2,288,560 | $704,000 | 0.02% |
| Tekla Capital Management LLC | 446,099 | $137,000 | 0.01% |
| Realta Investment Advisors | 26,000 | $7,000 | 0.00% |
| Virtu Financial LLC | 34,991 | $11,000 | 0.00% |
| Baker Brothers Advisors | 505,262 | $155,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $6,000 | 0.00% |
| MORGAN STANLEY | 1,160,098 | $356,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 18,333 | $6,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 102,725 | $31,000 | 0.00% |